Showing content from https://pubmed.ncbi.nlm.nih.gov/25417231/ below:
Cancer survival: an overview of measures, uses, and interpretation
. 2014 Nov;2014(49):145-86. doi: 10.1093/jncimonographs/lgu024. Cancer survival: an overview of measures, uses, and interpretation
Affiliations
Affiliations
- 1 Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD (AM, AN, NH, HC); Division of Cancer Registration and Surveillance, National Cancer Center, Goyang-si Gyeonggi-do, Korea (HC); Information Management Services, Inc., Calverton MD (GEK, JG); Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH, Geisel School of Medicine at Dartmouth, Hanover, NH, Department of Veterans Affairs Medical Center, Veterans Affairs Outcomes Group, White River Junction, VT (SW, LMS). mariotta@mail.nih.gov.
- 2 Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD (AM, AN, NH, HC); Division of Cancer Registration and Surveillance, National Cancer Center, Goyang-si Gyeonggi-do, Korea (HC); Information Management Services, Inc., Calverton MD (GEK, JG); Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH, Geisel School of Medicine at Dartmouth, Hanover, NH, Department of Veterans Affairs Medical Center, Veterans Affairs Outcomes Group, White River Junction, VT (SW, LMS).
Item in Clipboard
Cancer survival: an overview of measures, uses, and interpretation
Angela B Mariotto et al. J Natl Cancer Inst Monogr. 2014 Nov.
. 2014 Nov;2014(49):145-86. doi: 10.1093/jncimonographs/lgu024. Affiliations
- 1 Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD (AM, AN, NH, HC); Division of Cancer Registration and Surveillance, National Cancer Center, Goyang-si Gyeonggi-do, Korea (HC); Information Management Services, Inc., Calverton MD (GEK, JG); Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH, Geisel School of Medicine at Dartmouth, Hanover, NH, Department of Veterans Affairs Medical Center, Veterans Affairs Outcomes Group, White River Junction, VT (SW, LMS). mariotta@mail.nih.gov.
- 2 Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD (AM, AN, NH, HC); Division of Cancer Registration and Surveillance, National Cancer Center, Goyang-si Gyeonggi-do, Korea (HC); Information Management Services, Inc., Calverton MD (GEK, JG); Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH, Geisel School of Medicine at Dartmouth, Hanover, NH, Department of Veterans Affairs Medical Center, Veterans Affairs Outcomes Group, White River Junction, VT (SW, LMS).
Item in Clipboard
Abstract
Survival statistics are of great interest to patients, clinicians, researchers, and policy makers. Although seemingly simple, survival can be confusing: there are many different survival measures with a plethora of names and statistical methods developed to answer different questions. This paper aims to describe and disseminate different survival measures and their interpretation in less technical language. In addition, we introduce templates to summarize cancer survival statistic organized by their specific purpose: research and policy versus prognosis and clinical decision making.
Published by Oxford University Press 2014.
PubMed Disclaimer
Similar articles
- Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
- Traces of intact paraben molecules in endometrial carcinoma.
Dogan S, Tongur T, Erkaymaz T, Erdogan G, Unal B, Sik B, Simsek T. Dogan S, et al. Environ Sci Pollut Res Int. 2019 Oct;26(30):31158-31165. doi: 10.1007/s11356-019-06228-1. Epub 2019 Aug 28. Environ Sci Pollut Res Int. 2019. PMID: 31463755
- Observed and Expected Survival in Men and Women After Suffering a STEMI.
Pascual I, Hernandez-Vaquero D, Almendarez M, Lorca R, Escalera A, Díaz R, Alperi A, Carnero M, Silva J, Morís C, Avanzas P. Pascual I, et al. J Clin Med. 2020 Apr 19;9(4):1174. doi: 10.3390/jcm9041174. J Clin Med. 2020. PMID: 32325887 Free PMC article.
References
-
- Cho H, Mariotto AB, Schwartz LM, Luo J, Woloshin S. When do changes in cancer survival mean progress? The insight from population incidence and mortality. J Natl Cancer Inst Monogr. 2014;49:187–197. - PMC - PubMed
-
- Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101–121. - PubMed
-
- Ederer F, Heise H. Instructions to IBM 650 Programmers in Processing Survival Computations. Methodological Note no. 10, End Results Evaluation Section. Technical Report. Bethesda, MD: National Cancer Insitute; 1959.
-
- Marubini E, Morabito A, Valsecchi MG. Prognostic factors and risk groups: some results given by using an algorithm suitable for censored survival data. Stat Med. 1983;2(2):295–303. - PubMed
-
- Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982;38(4):933–942. - PubMed
RetroSearch is an open source project built by @garambo
| Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3